This work considers the feasibility of using a novel optical fiber-based sensor, employing a terbium-doped gadolinium oxysulfide (Gd2O2S:Tb) inorganic scintillator, as a real-time in vivo dosimetry solution for applications in low-dose-rate (LDR) prostate brachytherapy (BT). This study specifically considers the influence of scintillator geometry (hemisphere tip versus cylindrical cavity), polymethyl methacrylate (PMMA) fiber core diameter (0.5 versus 1.0 mm), and sensor housing material (stainless steel versus plastic) on the measured scintillation signal. Characterization measurements were performed using a silicon photon-multiplier (SiPM) detector and a commercial water phantom system, integrated with custom 3-D printed components to allow for precise positioning of the LDR BT radiation source with respect to the optical fiber sensor (OFS). Significant differences in the rate of fall-off in the scintillation signal, with distance from the source, were observed between the different scintillator geometries considered. The hemisphere tip geometry was shown to be the most accurate, tracking with the expected fall-off in dose-rate, within measurement uncertainty. Reducing the fiber core diameter from 1.0 to 0.5 mm resulted in a sixfold reduction in the detected scintillation signal. A further 57% reduction was observed when housing the 0.5-mm fiber within a stainless steel LDR BT needle applicator. Initial results demonstrate the feasibility of employing an OFS, for applications in LDR BT, given the excellent agreement of measurements with theoretical expectations. Furthermore, a calibration process has been described for converting the detected scintillation signal into absorbed dose/dose rate, using our water phantom-based experimental setup.